Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …

Importance In early 2020, the United States declared a public health emergency in response
to coronavirus disease 2019 (COVID-19) and implemented a variety of social distancing …

Purpose To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill
patients with coronavirus disease 2019 (COVID-19). Methods Critically ill adults with COVID-19 …

Background There is an increasing interest in clinical prediction tools that can achieve high
prediction accuracy and provide explanations of the factors leading to increased risk of …

Importance Randomized clinical trials (RCTs) of therapeutic-dose heparin in patients hospitalized
with COVID-19 produced conflicting results, possibly due to heterogeneity of treatment …

Abstract Machine learning models may be integrated into clinical decision support (CDS)
systems to identify children at risk of specific diagnoses or clinical deterioration to provide …

Interventions Patients were randomized to receive either open-label aspirin (n= 565), a
P2Y12 inhibitor (n= 455), or no antiplatelet therapy (control; n= 529). Interventions were …

Importance Sepsis is a leading cause of death among children worldwide. Current pediatric-specific
criteria for sepsis were published in 2005 based on expert opinion. In 2016, the …

BACKGROUND: Recent decision rules for the management of febrile infants support the
identification of infants at higher risk of serious bacterial infections (SBIs) without the …

Importance Genotype-guided prescribing in pediatrics could prevent adverse drug reactions
and improve therapeutic response. Clinical pharmacogenetic implementation guidelines …